Objective To discuss the preservation solution (PS) contamination and initial experience of liver transplantation from organ donation by citizens after death and initial experience. Methods The 78 liver transplant recipients were divided into positive group and negative group based on the finding of the culture of PS. The positive group received the sequential therapy of antibiotics with ertapenem and imipenem for one week, and the negative group stopped using imipenem. The situation of PS contamination and infection after liver transplantation and prognosis during the follow-up 3 months of the recipients were analyzed. Results PS culture positive rate was 41.03%, and 33 strains of pathogens were isolated. The most common pathogenic bacteria were gram-negative bacilli (9 strains, 27.27%) and coagulase –negative staphylococci (9 strains, 27.27%). The infection rate after liver transplantation was 31.25% and 13.04%, respectively, in positive group and negative group (χ2=3.837, P=0.048). The most frequent infection sites were lower respiratory tract (5 cases, 31.25%), abdominal cavity (5 cases, 31.25%) and surgical incision (4 cases, 25.00%). There was no significant difference in postoperative infection rate among patients with different CTP, MELD and surgical methods (P>0.05). One case (1.28%) was infected with the same pathogenic bacteria as PS contamination 3 weeks after liver transplantation, and died of multiple organ failure. There was no significantly difference in the acute rejection rate (1,3.13% and 2, 4.35%) and mortality (2,6.25% and 5,10.87%) between the two groups (P>0.05). Conclusion Contamination of the PS is frequent in liver transplantation, and it is the risk factor for postoperative infection of recipients. Early targeted antimicrobial treatment against pathogens cultured from PS play a positive role in reducing the contamination-associated infection rate after liver transplantation.
Published in | Science Discovery (Volume 9, Issue 4) |
DOI | 10.11648/j.sd.20210904.17 |
Page(s) | 171-177 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
Bacterial Contamination, Preservation Solution, Liver, Transplantation, Recipient Infection, Ertapenem
[1] | Dorschner P, McElroy LM, Ison MG. Nosocomial infections within the first month of solid organ transplantation. Transpl Infect Dis, 2014; 16:171–87. |
[2] | Avkan-Oguz V, Ozkardesler S, Unek T, et al. Risk factors for early bacterial infections in liver transplantation. Transplant Proc, 2013; 45:993–7. |
[3] | Fishman JA. From the classic concepts to modern practice. Clin Microbiol Infect, 2014; 20:4–9. |
[4] | Oriol I, Sabé N, Tebé C, et al. Clinical impact of culture-positive preservation fluid on solid organ transplantation: A systematic review and meta-analysis. Transplantation Reviews, 2018; 32: 85–91. |
[5] | Janny S, Bert F, Dondero F, et al. Microbiological findings of culture-positive preservation fluid in liver transplantation. Transpl Infect Dis, 2011; 13: 9-14. |
[6] | Audet M, Piardi T, Panaro F, et al. Incidence and clinical significance of bacterial and fungal contamination of the preservation solution in liver transplantation. Transpl Infect Dis, 2011; 13:84–8. |
[7] | 中华医学会器官移植学分会.中国心脏死亡器官捐献工作指南(第2版)[J/CD].中华移植杂志:电子版,2012; 6(3):221-224. |
[8] | 中华医学会器官移植学分会.中国肝移植免疫抑制治疗与排斥反应诊疗规范( 2019 版) [J/CD].中华移植杂志: 电子版, 2019, 13( 4) : 262-268. |
[9] | 中华人民共和国卫生部.医院感染诊断标准(试行)[J].中华医药杂志, 2001;81(5): 314-320. |
[10] | Oriol I, Lladó L, Vila M, et al. The Etiology, Incidence, and Impact of Preservation Fluid Contamination during Liver Transplantation. PLoS ONE, 2016; 11(8): e0160701. |
[11] | 臧晓青,钟林,彭志海.肝移植后感染的遗传易感性研究[J].中华临床医师杂志(电子版),2013;7(1):238-240. |
[12] | Garcia-Zamora C, Segura J, Lopez-Lopez V, et al. Clinical Significance of Contamination of the Preservation Solution in Liver Transplantation. Transplant Proc, 2015; 47, 2322-23. |
[13] | Ruiz P, Gastaca M, Gonzalez J, et al. Incidence and Clinical Relevance of Bacterial Contamination in Preservation Solution for Liver Transplantation. Transplant Proc, 2009; 41, 2169–71. |
[14] | Sauget M, Verdy S, Slekovec C, et al. Bacterial contamination of organ graft preservation solution and infection after transplantation. Transpl Infect Dis, 2011; 13:331-4. |
[15] | Levesque E, Suet G, Merle JC, et al. Candida vascular complication in a liver transplant recipient due to yeast contamination of preservation solution. Transpl Infect Dis, 2014; 16(5):827–9. |
[16] | Nery JR, Weppler D, Ketchum P, et al: Donor infection and primary nonfunction in liver transplantation. Transplant Proc, 1997; 29: 481–83. |
[17] | Bud O, Golling M, Von Frankenberg M, et al. Intramucosal pH and serum endotoxin concentrations as early predictive parameters for primary nonfunction after experimental liver transplantation. Transplant Proc, 2000; 32: 2537–38. |
[18] | Chaim FH, Boin IF, Ataide EC,et al..Perfusion fluid contamination in relation to recipient survival and acute cellular rejection in orthotopic liver transplantation: retrospective analysis.Transplant Proc. 2011,43(4):1313-5. |
[19] | 赵纪强,霍枫,李鹏,等. 中国心脏死亡器官捐献工作发展及影响因素: 单中心经验[J/CD]. 中华移植杂志: 电子版, 2017;11( 1) : 32-36. |
[20] | Shah PM, Isaacs RD. Ertapenem, the first of a new group of carbapenems. J. Antimicrob Chemother, 2003; 52:538–542. |
[21] | Goegele H, Berger N, Kafka R, et al. Course of transplant recipients treated with Ertapenem in the prophylaxis and treatment of infections: a first experience. Eur Surg, 2007; 39(3): 196–202. |
[22] | Oliva A,Scorzolini L, Cipolla A, et al. In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value. J Antimicrob Chemother, 2017; 72: 1981–1984. |
[23] | Piedra-Carrasco N, Miguel L, Fàbrega A, et al. Effectiveness of a double-carbapenem regimen in a KPC-Producing Klebsiella pneumoniae infection in an immunocompromised patient. Microbial Drug Resistance, 2018; 24(2), 199-202. |
[24] | Botterel F, Foulet F, LegrandP,etal. Yeast contamination of kidney, liver and cardiac preservation solutions before graft: need for standardisation of microbial evaluation. J Hosp Infect, 2010; 76:52-5. |
[25] | Albano L, Bretagne S, Mamzer-Bruneel M-F, et al. Evidence that graft-site candidiasis after kidney transplantation is acquired during organ recovery: a multicenter study in France. Clin Infect Dis, 2009; 48: 194-202. |
APA Style
Zhao Jiqiang, Zhao Jiquan, Huo Feng, Wang Shaping, Zheng Yujian. (2021). Preliminary Analysis of Contamination in Liver Preservation Solution and Prophylaxis for Post-transplant Infection. Science Discovery, 9(4), 171-177. https://doi.org/10.11648/j.sd.20210904.17
ACS Style
Zhao Jiqiang; Zhao Jiquan; Huo Feng; Wang Shaping; Zheng Yujian. Preliminary Analysis of Contamination in Liver Preservation Solution and Prophylaxis for Post-transplant Infection. Sci. Discov. 2021, 9(4), 171-177. doi: 10.11648/j.sd.20210904.17
AMA Style
Zhao Jiqiang, Zhao Jiquan, Huo Feng, Wang Shaping, Zheng Yujian. Preliminary Analysis of Contamination in Liver Preservation Solution and Prophylaxis for Post-transplant Infection. Sci Discov. 2021;9(4):171-177. doi: 10.11648/j.sd.20210904.17
@article{10.11648/j.sd.20210904.17, author = {Zhao Jiqiang and Zhao Jiquan and Huo Feng and Wang Shaping and Zheng Yujian}, title = {Preliminary Analysis of Contamination in Liver Preservation Solution and Prophylaxis for Post-transplant Infection}, journal = {Science Discovery}, volume = {9}, number = {4}, pages = {171-177}, doi = {10.11648/j.sd.20210904.17}, url = {https://doi.org/10.11648/j.sd.20210904.17}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sd.20210904.17}, abstract = {Objective To discuss the preservation solution (PS) contamination and initial experience of liver transplantation from organ donation by citizens after death and initial experience. Methods The 78 liver transplant recipients were divided into positive group and negative group based on the finding of the culture of PS. The positive group received the sequential therapy of antibiotics with ertapenem and imipenem for one week, and the negative group stopped using imipenem. The situation of PS contamination and infection after liver transplantation and prognosis during the follow-up 3 months of the recipients were analyzed. Results PS culture positive rate was 41.03%, and 33 strains of pathogens were isolated. The most common pathogenic bacteria were gram-negative bacilli (9 strains, 27.27%) and coagulase –negative staphylococci (9 strains, 27.27%). The infection rate after liver transplantation was 31.25% and 13.04%, respectively, in positive group and negative group (χ2=3.837, P=0.048). The most frequent infection sites were lower respiratory tract (5 cases, 31.25%), abdominal cavity (5 cases, 31.25%) and surgical incision (4 cases, 25.00%). There was no significant difference in postoperative infection rate among patients with different CTP, MELD and surgical methods (P>0.05). One case (1.28%) was infected with the same pathogenic bacteria as PS contamination 3 weeks after liver transplantation, and died of multiple organ failure. There was no significantly difference in the acute rejection rate (1,3.13% and 2, 4.35%) and mortality (2,6.25% and 5,10.87%) between the two groups (P>0.05). Conclusion Contamination of the PS is frequent in liver transplantation, and it is the risk factor for postoperative infection of recipients. Early targeted antimicrobial treatment against pathogens cultured from PS play a positive role in reducing the contamination-associated infection rate after liver transplantation.}, year = {2021} }
TY - JOUR T1 - Preliminary Analysis of Contamination in Liver Preservation Solution and Prophylaxis for Post-transplant Infection AU - Zhao Jiqiang AU - Zhao Jiquan AU - Huo Feng AU - Wang Shaping AU - Zheng Yujian Y1 - 2021/06/09 PY - 2021 N1 - https://doi.org/10.11648/j.sd.20210904.17 DO - 10.11648/j.sd.20210904.17 T2 - Science Discovery JF - Science Discovery JO - Science Discovery SP - 171 EP - 177 PB - Science Publishing Group SN - 2331-0650 UR - https://doi.org/10.11648/j.sd.20210904.17 AB - Objective To discuss the preservation solution (PS) contamination and initial experience of liver transplantation from organ donation by citizens after death and initial experience. Methods The 78 liver transplant recipients were divided into positive group and negative group based on the finding of the culture of PS. The positive group received the sequential therapy of antibiotics with ertapenem and imipenem for one week, and the negative group stopped using imipenem. The situation of PS contamination and infection after liver transplantation and prognosis during the follow-up 3 months of the recipients were analyzed. Results PS culture positive rate was 41.03%, and 33 strains of pathogens were isolated. The most common pathogenic bacteria were gram-negative bacilli (9 strains, 27.27%) and coagulase –negative staphylococci (9 strains, 27.27%). The infection rate after liver transplantation was 31.25% and 13.04%, respectively, in positive group and negative group (χ2=3.837, P=0.048). The most frequent infection sites were lower respiratory tract (5 cases, 31.25%), abdominal cavity (5 cases, 31.25%) and surgical incision (4 cases, 25.00%). There was no significant difference in postoperative infection rate among patients with different CTP, MELD and surgical methods (P>0.05). One case (1.28%) was infected with the same pathogenic bacteria as PS contamination 3 weeks after liver transplantation, and died of multiple organ failure. There was no significantly difference in the acute rejection rate (1,3.13% and 2, 4.35%) and mortality (2,6.25% and 5,10.87%) between the two groups (P>0.05). Conclusion Contamination of the PS is frequent in liver transplantation, and it is the risk factor for postoperative infection of recipients. Early targeted antimicrobial treatment against pathogens cultured from PS play a positive role in reducing the contamination-associated infection rate after liver transplantation. VL - 9 IS - 4 ER -